Atb Cap Markets Weighs in on Ascend Wellness FY2024 Earnings

Ascend Wellness Holdings, Inc. (OTC:AAWH) – Analysts at Atb Cap Markets dropped their FY2024 earnings estimates for shares of Ascend Wellness in a report issued on Tuesday, November 12th. Atb Cap Markets analyst F. Gomes now expects that the company will post earnings per share of ($0.40) for the year, down from their previous forecast of ($0.32). The consensus estimate for Ascend Wellness’ current full-year earnings is ($0.32) per share. Atb Cap Markets also issued estimates for Ascend Wellness’ Q4 2024 earnings at ($0.08) EPS, FY2026 earnings at ($0.12) EPS, FY2027 earnings at ($0.11) EPS and FY2028 earnings at ($0.09) EPS.

Ascend Wellness Stock Down 6.8 %

Shares of OTC:AAWH opened at $0.47 on Friday. The company has a market capitalization of $99.66 million, a PE ratio of -1.13 and a beta of 1.69. Ascend Wellness has a 52 week low of $0.42 and a 52 week high of $1.82. The company has a debt-to-equity ratio of 2.61, a quick ratio of 1.29 and a current ratio of 1.47. The company’s fifty day moving average is $0.82 and its 200-day moving average is $0.95.

Ascend Wellness (OTC:AAWH) last announced its quarterly earnings data on Tuesday, November 12th. The company reported ($0.13) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.10) by ($0.03). The business had revenue of $141.65 million during the quarter, compared to analyst estimates of $144.13 million. Ascend Wellness had a negative net margin of 15.47% and a negative return on equity of 72.18%.

Ascend Wellness Company Profile

Ascend Wellness Holdings, Inc engages in the cultivation, manufacture, and distribution of cannabis consumer packaged goods in the United States. The company offers flower, pre-rolls, concentrates, vapes, edibles, tinctures, and other cannabis-related products under the Common Goods, SimplyHerb, Ozone, Ozone Reserve, Royale, Tunnel Vision, Miss Grass, Lowell Smokes, Edie Parker, 1906, and AiroPro brands.